# National CineMedia, Inc.: financial statements, quarterly

NCMI · Nasdaq · CIK 1377630 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ncmi.md) · [Financials](/companies/ncmi/financials.md) · [Filings](/companies/ncmi/filings.md) · [Insiders](/companies/ncmi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ncmi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-28) | Q4 FY2023 (2023-12-28) | period not labelled (2024-03-28) | Q1 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | Q4 FY2024 (2024-12-26) | Q1 FY2025 (2025-03-27) | Q2 FY2025 (2025-06-26) | Q3 FY2025 (2025-09-25) | Q4 FY2025 (2026-01-01) | Q1 FY2026 (2026-04-02) | Q2 FY2026 (2026-07-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.7](/filings/0000950170-24-121466.md) | [90.8 d](/filings/0001193125-26-076788.md) | [37.4](/filings/0000950170-25-064502.md) | [54.7](/filings/0000950170-25-103079.md) | [62.4](/filings/0001193125-25-258597.md) | [86.3 d](/filings/0001193125-26-076788.md) | [34.9](/filings/0001193125-26-219502.md) | [51.8](/filings/0001193125-26-344956.md) | [63.4](/filings/0001193125-25-258597.md) | [93.2 d](/filings/0001193125-26-076788.md) | [34.0](/filings/0001193125-26-219502.md) | [58.4](/filings/0001193125-26-344956.md) |
| Cost of revenue | $m | [2.6](/filings/0000950170-24-121466.md) | [3.7 d](/filings/0001193125-26-076788.md) | [3.6](/filings/0000950170-25-064502.md) | [3.7](/filings/0000950170-25-103079.md) | [3.3](/filings/0001193125-25-258597.md) | [3.1 d](/filings/0001193125-26-076788.md) | [3.1](/filings/0001193125-26-219502.md) | [3.2](/filings/0001193125-26-344956.md) | [3.2](/filings/0001193125-25-258597.md) | [3.6 d](/filings/0001193125-26-076788.md) | [4.0](/filings/0001193125-26-219502.md) | [3.7](/filings/0001193125-26-344956.md) |
| Operating income | $m | [(12.3)](/filings/0000950170-24-121466.md) | [20.4 d](/filings/0001193125-26-076788.md) | [(22.7)](/filings/0000950170-25-064502.md) | [(9.3)](/filings/0000950170-25-103079.md) | [(7.5)](/filings/0001193125-25-258597.md) | [19.9 d](/filings/0001193125-26-076788.md) | [(23.9)](/filings/0001193125-26-219502.md) | [(12.0)](/filings/0001193125-26-344956.md) | [(1.8)](/filings/0001193125-25-258597.md) | [23.8 d](/filings/0001193125-26-076788.md) | [(26.9)](/filings/0001193125-26-219502.md) | [(12.8)](/filings/0001193125-26-344956.md) |
| Income tax | $m | [0.0](/filings/0000950170-24-121466.md) | [0.0 d](/filings/0001193125-26-076788.md) | [0.0](/filings/0000950170-25-064502.md) | [0.0](/filings/0000950170-25-103079.md) | [0.0](/filings/0001193125-25-258597.md) | [0.2 d](/filings/0001193125-26-076788.md) | [0.0](/filings/0001193125-26-219502.md) | [0.0](/filings/0001193125-26-344956.md) | [0.0](/filings/0001193125-25-258597.md) | [0.0 d](/filings/0001193125-26-076788.md) | [0.0](/filings/0001193125-26-219502.md) | [0.0](/filings/0001193125-26-344956.md) |
| Net income | $m | [182](/filings/0000950170-24-121466.md) | [23.7 d](/filings/0001193125-26-076788.md) | [(34.7)](/filings/0000950170-25-064502.md) | [(8.7)](/filings/0000950170-25-103079.md) | [(3.6)](/filings/0001193125-25-258597.md) | [24.7 d](/filings/0001193125-26-076788.md) | [(30.7)](/filings/0001193125-26-219502.md) | [(10.7)](/filings/0001193125-26-344956.md) | [1.6](/filings/0001193125-25-258597.md) | [29.3 d](/filings/0001193125-26-076788.md) | [(28.6)](/filings/0001193125-26-219502.md) | [(9.9)](/filings/0001193125-26-344956.md) |
| Diluted EPS | $ per share | [2.89](/filings/0000950170-24-121466.md) | not reported | [(0.36)](/filings/0000950170-25-064502.md) | [(0.09)](/filings/0000950170-25-103079.md) | [(0.04)](/filings/0001193125-25-258597.md) | not reported | [(0.32)](/filings/0001193125-26-219502.md) | [(0.11)](/filings/0001193125-26-344956.md) | [0.02](/filings/0001193125-25-258597.md) | not reported | [(0.31)](/filings/0001193125-26-219502.md) | [(0.11)](/filings/0001193125-26-344956.md) |
| Basic EPS | $ per share | [2.89](/filings/0000950170-24-121466.md) | not reported | [(0.36)](/filings/0000950170-25-064502.md) | [(0.09)](/filings/0000950170-25-103079.md) | [(0.04)](/filings/0001193125-25-258597.md) | not reported | [(0.32)](/filings/0001193125-26-219502.md) | [(0.11)](/filings/0001193125-26-344956.md) | [0.02](/filings/0001193125-25-258597.md) | not reported | [(0.31)](/filings/0001193125-26-219502.md) | [(0.11)](/filings/0001193125-26-344956.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-28) | FY2023 (2023-12-28) | period not labelled (2024-03-28) | Q1 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | FY2024 (2024-12-26) | Q1 FY2025 (2025-03-27) | Q2 FY2025 (2025-06-26) | Q3 FY2025 (2025-09-25) | FY2025 (2026-01-01) | Q1 FY2026 (2026-04-02) | Q2 FY2026 (2026-07-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [17.2](/filings/0001377630-23-000189.md) | [34.6](/filings/0000950170-25-034706.md) | [57.1](/filings/0001377630-24-000077.md) | [53.8](/filings/0000950170-24-090775.md) | [49.4](/filings/0000950170-24-121466.md) | [75.1](/filings/0001193125-26-076788.md) | [59.7](/filings/0000950170-25-064502.md) | [37.2](/filings/0000950170-25-103079.md) | [29.9](/filings/0001193125-25-258597.md) | [34.6](/filings/0001193125-26-344956.md) | [48.6](/filings/0001193125-26-219502.md) | [43.1](/filings/0001193125-26-344956.md) |
| Current assets | $m | [103](/filings/0001377630-23-000189.md) | [144](/filings/0000950170-25-034706.md) | [117](/filings/0001377630-24-000077.md) | [116](/filings/0000950170-24-090775.md) | [126](/filings/0000950170-24-121466.md) | [178](/filings/0001193125-26-076788.md) | [124](/filings/0000950170-25-064502.md) | [101](/filings/0000950170-25-103079.md) | [95.7](/filings/0001193125-25-258597.md) | [138](/filings/0001193125-26-344956.md) | [126](/filings/0001193125-26-219502.md) | [112](/filings/0001193125-26-344956.md) |
| Total assets | $m | [539](/filings/0001377630-23-000189.md) | [568](/filings/0000950170-25-034706.md) | [539](/filings/0001377630-24-000077.md) | [527](/filings/0000950170-24-090775.md) | [526](/filings/0000950170-24-121466.md) | [569](/filings/0001193125-26-076788.md) | [504](/filings/0000950170-25-064502.md) | [462](/filings/0000950170-25-103079.md) | [452](/filings/0001193125-25-258597.md) | [491](/filings/0001193125-26-344956.md) | [469](/filings/0001193125-26-219502.md) | [446](/filings/0001193125-26-344956.md) |
| Current liabilities | $m | [51.8](/filings/0001377630-23-000189.md) | [58.4](/filings/0000950170-25-034706.md) | [42.5](/filings/0001377630-24-000077.md) | [47.5](/filings/0000950170-24-090775.md) | [51.1](/filings/0000950170-24-121466.md) | [73.5](/filings/0001193125-26-076788.md) | [54.3](/filings/0000950170-25-064502.md) | [57.9](/filings/0000950170-25-103079.md) | [50.5](/filings/0001193125-25-258597.md) | [62.1](/filings/0001193125-26-344956.md) | [69.3](/filings/0001193125-26-219502.md) | [60.7](/filings/0001193125-26-344956.md) |
| Total liabilities | $m | [130](/filings/0001377630-23-000189.md) | [133](/filings/0000950170-25-034706.md) | [136](/filings/0001377630-24-000077.md) | [139](/filings/0000950170-24-090775.md) | [141](/filings/0000950170-24-121466.md) | [157](/filings/0001193125-26-076788.md) | [133](/filings/0000950170-25-064502.md) | [112](/filings/0000950170-25-103079.md) | [101](/filings/0001193125-25-258597.md) | [115](/filings/0001193125-26-344956.md) | [124](/filings/0001193125-26-219502.md) | [112](/filings/0001193125-26-344956.md) |
| Long-term debt | $m | [10.0](/filings/0001377630-23-000189.md) | [10.0](/filings/0000950170-25-034706.md) | [10.0](/filings/0001377630-24-000077.md) | [10.0](/filings/0000950170-24-090775.md) | [10.0](/filings/0000950170-24-121466.md) | [10.0](/filings/0001193125-26-076788.md) | [0.0](/filings/0000950170-25-064502.md) | [0.0](/filings/0000950170-25-103079.md) | [0.0](/filings/0001193125-25-258597.md) | [12.0](/filings/0001193125-26-344956.md) | [12.0](/filings/0001193125-26-219502.md) | [12.0](/filings/0001193125-26-344956.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001377630-24-000042.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [0.0](/filings/0001377630-23-000189.md) | [0.0](/filings/0001377630-24-000042.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [409](/filings/0001377630-23-000189.md) | [435](/filings/0000950170-25-034706.md) | [402](/filings/0001377630-24-000077.md) | [388](/filings/0000950170-24-090775.md) | [386](/filings/0000950170-24-121466.md) | [411](/filings/0001193125-26-076788.md) | [371](/filings/0000950170-25-064502.md) | [350](/filings/0000950170-25-103079.md) | [351](/filings/0001193125-25-258597.md) | [375](/filings/0001193125-26-344956.md) | [345](/filings/0001193125-26-219502.md) | [334](/filings/0001193125-26-344956.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-28) | Q4 FY2023 (2023-12-28) | period not labelled (2024-03-28) | Q2 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | Q4 FY2024 (2024-12-26) | Q1 FY2025 (2025-03-27) | Q2 FY2025 (2025-06-26) | Q3 FY2025 (2025-09-25) | Q4 FY2025 (2026-01-01) | Q1 FY2026 (2026-04-02) | Q2 FY2026 (2026-07-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(26.8) d](/filings/0000950170-24-121466.md) | [15.6 d](/filings/0001193125-26-076788.md) | [24.1](/filings/0000950170-25-064502.md) | [7.7 d](/filings/0000950170-25-103079.md) | [(2.0) d](/filings/0001193125-25-258597.md) | [30.5 d](/filings/0001193125-26-076788.md) | [6.0](/filings/0001193125-26-219502.md) | [(4.9) d](/filings/0001193125-26-344956.md) | [(1.0) d](/filings/0001193125-25-258597.md) | [8.3 d](/filings/0001193125-26-076788.md) | [18.1](/filings/0001193125-26-219502.md) | [(1.5) d](/filings/0001193125-26-344956.md) |
| Capital expenditure | $m | [0.6 d](/filings/0000950170-24-121466.md) | [1.6 d](/filings/0001193125-26-076788.md) | [1.5](/filings/0000950170-25-064502.md) | [1.3 d](/filings/0000950170-25-103079.md) | [0.6 d](/filings/0001193125-25-258597.md) | [2.4 d](/filings/0001193125-26-076788.md) | [0.7](/filings/0001193125-26-219502.md) | [1.7 d](/filings/0001193125-26-344956.md) | [1.0 d](/filings/0001193125-25-258597.md) | [2.2 d](/filings/0001193125-26-076788.md) | [0.3](/filings/0001193125-26-219502.md) | [0.7 d](/filings/0001193125-26-344956.md) |
| Dividends paid | $m | [0.1 d](/filings/0000950170-24-121466.md) | [0.0 d](/filings/0001193125-26-076788.md) | [0.3](/filings/0000950170-25-064502.md) | [0.0 d](/filings/0000950170-25-103079.md) | [0.0 d](/filings/0001193125-25-258597.md) | [0.0 d](/filings/0001193125-26-076788.md) | [0.0](/filings/0001193125-26-219502.md) | [5.7 d](/filings/0001193125-26-344956.md) | [2.8 d](/filings/0001193125-25-258597.md) | [2.9 d](/filings/0001193125-26-076788.md) | [2.8](/filings/0001193125-26-219502.md) | [2.9 d](/filings/0001193125-26-344956.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-121466.md) | [0.0 d](/filings/0001193125-26-076788.md) | [0.0](/filings/0000950170-25-064502.md) | [0.0](/filings/0001377630-24-000077.md) | [1.9 d](/filings/0001193125-25-258597.md) | [2.0 d](/filings/0001193125-26-076788.md) | [8.8](/filings/0001193125-26-219502.md) | [9.9 d](/filings/0001193125-26-344956.md) | [0.0 d](/filings/0001193125-25-258597.md) | [3.3 d](/filings/0001193125-26-076788.md) | [1.0](/filings/0001193125-26-219502.md) | [0.2 d](/filings/0001193125-26-344956.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-29) | Q1 FY2023 (2023-03-30) | Q2 FY2023 (2023-06-29) | Q3 FY2023 (2023-09-28) | period not labelled (2024-03-28) | Q1 FY2024 (2024-06-27) | Q3 FY2024 (2024-09-26) | Q1 FY2025 (2025-03-27) | Q2 FY2025 (2025-06-26) | Q3 FY2025 (2025-09-25) | Q1 FY2026 (2026-04-02) | Q2 FY2026 (2026-07-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8.2](/filings/0001377630-23-000189.md) | [14.6](/filings/0001377630-24-000077.md) | [17.4](/filings/0000950170-24-090775.md) | [62.8](/filings/0000950170-24-121466.md) | [96.9](/filings/0000950170-25-064502.md) | [96.4](/filings/0000950170-25-103079.md) | [95.2](/filings/0001193125-25-258597.md) | [95.4](/filings/0001193125-26-219502.md) | [94.0](/filings/0001193125-26-344956.md) | [94.3](/filings/0001193125-25-258597.md) | [93.2](/filings/0001193125-26-219502.md) | [93.7](/filings/0001193125-26-344956.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 94,070,443 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-344956.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.